Drug Class Modifications Expected In Final Model Formulary, USP Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The number of designated drug classes will change based upon comments to the draft guidelines for Medicare formularies, USP exec says. However, “it’s too early to tell” if there will be more or fewer classes.